Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of Toronto

$27,000.00

Iron-Catalyzed Three-Componenet Amino(radio)fluroination of Monofluorinated Alkenes to Unprotected ß,ß-(radio)Difluoroamines

FY 2024-25

Summary
Radiopharmaceuticals are a special type of drug that contains radioactive material and are used in medical imaging or as treatments, such as for cancer. However, not all chemical reactions used in drug development work well when dealing with radioactive materials. One big challenge is safety concerns around radioactivity and the need for specialized techniques. Thus, there is a demand for more radiochemical reactions that can synthesize important drug structures. One such structure are the B,B-difluoroamines. These are molecules with two fluorine atoms attached to a carbon next to an amine group. Not many protocols allow for an easy synthesis because existing methods require harsh conditions that don’t work well in radiochemistry labs, and those that use carbon double-bond containing compounds-also known as alkenes- require conditions that are even more difficult to execute. Fortunately, our group has recently developed a simple, one-step method that addresses this issue and allows for facile translation, which is currently under review. This project aims to develop an easy one-step method to synthesize B,B-difluoroamines through organic chemistry and radiochemistry. We will first develop an organic chemistry method, which can then be adapted to radiochemistry with a few necessary adjustments to account for its specific challenges. Different alkene-containing compounds will be tested using this method to show its wide applicability. Then, the method will be automated, allowing for quick and easy synthesis of new radiopharmaceuticals. Developing new methods helps strengthen our understanding of not just radiochemistry, but fundamental organic chemistry synthesis, which can allow us to explore innovative ways to synthesize drug compounds such as radiopharmaceuticals.
Program
Master's Award: Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
529913
Name
Le Hannah N
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Iron-Catalyzed Three-Componenet Amino(radio)fluroination of Monofluorinated Alkenes to Unprotected ß,ß-(radio)Difluoroamines
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Difluoroamines; Drug Development; Organic Chemistry; Pharmacology; Positron Emission Tomography; Radiochemistry; Radioisotopes; Radiopharmaceuticals; Radiotracers; Tracer Development
Abstract
Radiopharmaceuticals are a special type of drug that contains radioactive material and are used in medical imaging or as treatments, such as for cancer. However, not all chemical reactions used in drug development work well when dealing with radioactive materials. One big challenge is safety concerns around radioactivity and the need for specialized techniques. Thus, there is a demand for more radiochemical reactions that can synthesize important drug structures. One such structure are the B,B-difluoroamines. These are molecules with two fluorine atoms attached to a carbon next to an amine group. Not many protocols allow for an easy synthesis because existing methods require harsh conditions that don’t work well in radiochemistry labs, and those that use carbon double-bond containing compounds-also known as alkenes- require conditions that are even more difficult to execute. Fortunately, our group has recently developed a simple, one-step method that addresses this issue and allows for facile translation, which is currently under review. This project aims to develop an easy one-step method to synthesize B,B-difluoroamines through organic chemistry and radiochemistry. We will first develop an organic chemistry method, which can then be adapted to radiochemistry with a few necessary adjustments to account for its specific challenges. Different alkene-containing compounds will be tested using this method to show its wide applicability. Then, the method will be automated, allowing for quick and easy synthesis of new radiopharmaceuticals. Developing new methods helps strengthen our understanding of not just radiochemistry, but fundamental organic chemistry synthesis, which can allow us to explore innovative ways to synthesize drug compounds such as radiopharmaceuticals.
Competitiondate
202412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Le, Hannah N
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~